In this study we examined the relationship between autophagy and apoptosis in diabetic rats after spinal cord injury (SCI), also we determined the role of autophagy in diabetes-aggravated neurological injury in vivo and in vitro. Our results showed that diabetes decreased the survival of neurons, promoted astrocytes proliferation, increased inflammatory cells infiltration and inhibited functional recovery after SCI. Diabetes was shown to confer increased activation of apoptotic pathways, along with an increase in autophagy; similar effects were also observed in vitro in neuronal PC12 cells. Treatment with rapamycin, an autophagy activator, partially abolished the adverse effect of diabetes, suggesting that diabetes may enhance neurological damage and suppress locomotor recovery after SCI, in addition to its effects on apoptosis and autophagy. In contrast, further stimulation of autophagy improved neurological function via inhibition of apoptosis. These results explained how diabetes exacerbates SCI in cellular level and suggested autophagy stimulation to be a new therapeutic strategy for diabetic SCI.
apoptosis 10 , suggesting a mechanistic link between autophagy and diabetes. Besides, autophagy has been shown to be activated in animal model of traumatic spinal cord injury 11 . We therefore hypothesised that the activation of autophagy plays an important role in cases of diabetic SCI.
Numerous studies suggested a strong link between autophagy and neurotrauma. It has been demonstrated that autophagy is activated in many neurotrauma models, including cerebral ischemia, traumatic head injury, and spinal cord injury 12 . Besides, the role of autophagy in neurotrauma is likely to depend on conditions characteristic of a given disease. On the one hand, the promotion of autophagy was considered to provide a neuroprotective function in models of neonatal hypoxia-ischemia-induced brain injury, closed head injury and spinal cord injury 13, 14 . On the other hand, several other studies reported that autophagy also causes cell death (autophagic cell death) in focal cerebral ischemia 15 and neonatal cerebral ischemia 16 . However whether the function of autophagy is protective or detrimental for neural tissue in diabetes mellitus after SCI remains to be elucidated.
Here, we examined the effects of diabetes mellitus on autophagy, apoptosis, and neurological damage (increased inflammation, astrocytes proliferation and neuronal loss) in the context of a spinal cord injury. Rats were examined with and without rapamycin, a classical autophagy agonist widely applied in vivo and in vitro 17, 18 , to better define the role of autophagy in acute SCI in diabetic rats, and to identify the internal mechanism involved in apoptosis. Finally, the mechanism of action underlying pathology in diabetic SCI rats is further verified via in vitro analysis in PC12 cells.
Results

Successful induction of SCI in a murine model of Type 1 diabetes. No differences in fasting plasma
glucose (FPG) levels or mean body weight of rats were detected between diabetes and control groups before streptozotocin (STZ) injection. Four weeks after the induction of diabetes (prior to SCI), the mean weight of the diabetic animals was 175.67 ± 8.47 g and FPG levels were 28.57 ± 1.82 mmol/L, compared with a mean weight of 263.83 ± 11.41 g, and FPG levels of 6.47 ± 0.36 mmol/L and 5.42 ± 0.23 mmol/L, respectively for controls (P < 0.05 for both; Fig. 1A,B) . Following induction of SCI, rats in both the SCI and diabetes + SCI groups showed dramatic and bilateral hind limb paralysis with no movement at all or only slight movements of a joint in the first few hours post-injury (Fig. 1C) . Twelve diabetic rats died within the first week after SCI, for a mortality rate of 18.75%; two deaths were recorded in the control group.
Diabetes decreases neuronal survival, promotes astrocytes proliferation, increases inflammation and inhibits functional recovery after SCI.
To evaluate the effects of diabetes on locomotor recovery after SCI, Basso, Beattie, and Bresnahan (BBB) scores and inclined plane test results were measured for 4 weeks. No significant differences in BBB scores were detected between the SCI and diabetes + SCI groups 3 days after SCI (P > 0.05; Fig. 2A) ; however, diabetes + SCI rats BBB scores were significantly lower than that of SCI controls at 7, 14, 21, and 28 d after contusion (P < 0.05). Similarly, the inclined plane test scores were consistently lower in diabetes + SCI rats at 14, 21, and 28 d after injury (P < 0.05; Fig. 2B ). These data suggest that diabetes may suppress functional improvement of locomotor activity after SCI. Histomorphology differences between the sham control, SCI, and diabetes + SCI groups were analysed by H&E staining 7 days after contusion (Fig. 2C) . Progressive destruction of the dorsal white matter and central grey matter was evident in SCI rats relative to the sham control group, indicative of spinal cord injury. Comparisons between the SCI and diabetes + SCI groups revealed significant adverse effects, including increased infiltration of inflammatory cells and a larger cavity involving the lateral funiculi, dorsal and central gray matter in the diabetes + SCI group. Direct analysis of neuronal survival in the spinal cord was investigated using Nissl staining and immunohistochemistry [for NeuN, a common neuronal marker] 7 days after injury (Fig. 2D) . The positive cells of Nissl and NeuN significantly decreased in the spinal cord lesions in SCI rats, with further reductions seen in the diabetes + SCI group (P < 0.05; Fig. 2E ). To assess the proliferation of astrocytes in the injured spinal cord, Immunohistochemistry staining for glial fibroblast acid protein (GFAP) was performed in each group (Fig. 2F ). As is shown in Fig. 2G , diabetes mellitus significantly increased the IA value of GFAP expression in spinal cord after SCI (P < 0.05). To determine the inflammation in spinal cord lesions, Immunofluorescence staining for CD45 (a common leukocyte marker) and Immunohistochemistry staining for CD68 (a macrophages marker) was performed (Fig. 2H ). In the image of Fig. 2I , we found that diabetes significantly increased the number of CD45/CD68 positive cells in spinal cord lesions (P < 0.05). These results show that diabetes decreased neuronal survival, promoted astrocytes proliferation, increased inflammation and inhibited functional recovery after SCI.
The adverse effect of diabetes is related to apoptosis in SCI rats. To assess the role of apoptosis in the injured spinal cord, Immunohistochemistry staining for C-caspase3 and double staining for NeuN/ TUNEL were performed in each group. Immunohistochemical analysis of diabetes-induced apoptosis in SCI revealed significant increases in the number of C-caspase 3 positive cells in diabetes + SCI rats compared with that of SCI rats (P < 0.05; Fig. 3A ,B). Double staining for NeuN (red)/TUNEL (green) was performed to observe the apoptosis in neurons of injured spinal cord (Fig. 3C ). As is shown in Fig. 3D , the percentage of the apoptotic neurons significantly increased in the spinal cord lesions in SCI rats, with further increments seen in the diabetes + SCI group (P < 0.05). Increased expression of C-caspase 3, Bax, and Bcl2 were also detected by Western blotting, revealing strong induction of both C-caspase-3 and Bax after SCI contusion (Fig. 3E ). Further increases in both C-caspase 3 and Bax were detected in the diabetes + SCI groups relative to the SCI group 7 days after contusion (P < 0.05; Fig. 3F ); the reverse was seen for Bcl2, with progressively lower levels seen in the SCI and diabetes + SCI groups relative to controls (P < 0.05; Fig. 3G ). Taken together, these data suggest a direct link between the adverse effects of diabetes and apoptosis in SCI rats.
Activation of autophagy in diabetic rats after SCI. We used transmission electron microscopy (TEM) to observed autophagosomes, double membrane structures containing parts of cytoplasmic organelles, in the spinal cords of SCI and diabetes + SCI rats (Fig. 4A ). To molecularly confirm the induction of autophagy, we used Immunohistochemistry to detect the autophagosomal marker LC3II in the cytoplasm of affected cells. LC3II-positive cells were shown to be increased in spinal cord lesions, relative to controls, with further induction seen in the injured spinal cords of diabetic rats (P < 0.05; Fig. 4B ,C). Protein expression was confirmed by Western blot analysis using antibodies targeting LC3II/LC3I and Beclin1, with results broadly consistent with that of Immunohistochemistry (P < 0.05; Fig. 4D ,E). Despite clear evidence of autophagosomes, detection of autophagosomes alone does not indicate activation of the autophagic process. Autophagy is a dynamic mechanism of degradation of damaged cellular organelles and long-lived proteins. The protein p62 is a substrate of the autophagic process, and its expression is considered a marker of autophagic flux 19 . Expression of p62 in diabetic rats after SCI was detected by Western blot analysis, revealing levels much lower than that of SCI rats and controls (P < 0.05; Fig. 4D,F) . These results indicated that autophagy activation plays a role in the exacerbation of disease in diabetic rats after spinal cord injury.
The adverse effects of diabetes in SCI are inhibited by autophagy agonist rapamycin. To determine the effects of autophagy activation during SCI recovery in diabetic rats, rapamycin, a classical autophagy agonist, was used to treat diabetic rats after SCI. BBB scores and angle of incline test results revealed significant improvements in movement functional recovery in diabetic SCI rats following rapamycin treatment relative to diabetes + SCI alone (Fig. 5A,B) . HE staining revealed significant reductions in the damage to the dorsal white matter and central grey matter following rapamycin treatment in the diabetes + SCI group, with concomitant decreases in infiltration of inflammatory cells and a smaller cavity in lesion site (Fig. 5C ). The effect of rapamycin on the survival of neurons in diabetic spinal cord was investigated using Nissl staining and immunohistochemistry (for NueN) 7 days after injury ( Fig. 5D ). Staining revealed lower loss of positively stained neurons in the lesions of rapamycin-treated diabetic rats, compared to the diabetes + SCI group (P < 0.05; Fig. 5E ). Immunohistochemistry (for GFAP) results revealed significantly decreased the IA value of GFAP expression in diabetic SCI rats following rapamycin treatment relative to diabetes + SCI alone ((P < 0.05; Fig. 5F ,G). The effect of rapamycin on inflammation in diabetic spinal cord was investigated using Immunofluorescence (for CD45) and Immunohistochemistry (for CD68) 7 days after injury (Fig. 5H ). As is shown in Fig.5I , rapamycin significantly reduced the number of CD45/CD68 positive cells in diabetic SCI (P < 0.05). Taken together, these results provide that stimulation of autophagy increases neuronal survival, suppresses astrocytes proliferation, inhibits inflammation and promotes functional recovery of diabetes after SCI. Further increased autophagy by rapamycin reduces the level of apoptosis in diabetic rats after SCI. The expression levels of apoptosis-related proteins (C-caspase 3, Bax, and Bcl2) and autophagy-associated proteins (LC3-II/LC3-I, Beclin1, and p62) were evaluated to address the mechanism of autophagy induction in diabetic SCI rats. Rapamycin treatment was shown to significantly increase the LC3-II/LC3-I ratio and Beclin1 expression in the diabetes + SCI group (P < 0.05; Fig. 6A -C); significant decreases were seen for p62 (Fig. 6A,D) . In contrast, both C-caspase 3 and Bax levels were decreased in diabetic SCI rats following rapamycin treatment; Bcl2 expression was also reduced in the rapamycin-treated group (P < 0.05; Fig. 6E ,F,H). These results suggest that rapamycin-induced autophagy inhibits apoptosis in diabetic SCI rats, indicating a potential neuroprotective role for autophagy in cases of SCI.
Up-regulation of autophagy suppresses high-glucose-aggravated apoptosis in an in vitro oxidative damage model. Hyperglycaemia plays a major role in the development of diabetes-associated diseases. Thus, high glucose was used to simulate the hyperglycaemic condition of diabetes in vitro. To further test our hypothesis that hyperglycaemia-induced autophagy contributes to neuroprotection in vitro, PC12 cells were subjected to oxidative damage via treatment with H 2 O 2 , and then incubated in the presence of high glucose concentrations with or without rapamycin. In CCK-8 assays, cell viability was dramatically inhibited following H 2 O 2 treatment in the presence of high glucose concentrations, which was significantly attenuated in the presence of rapamycin (P < 0.05; Fig. 7A) . Next, the effect of high glucose concentrations on autophagy was evaluated using immunofluorescence. Increased levels of LC3-II puncta in the cytoplasm of H 2 O 2 -treated PC12 cells were seen in the presence of high glucose concentrations (Fig. 7B) ; the number of LC3-II puncta in the high glucose + H 2 O 2 group was further increased following the addition of rapamycin. High glucose concentrations significantly increased the LC3-II/LC3-I ratio and Beclin1 expression in H 2 O 2 -treated PC12 cells, which was further enhanced by the addition of rapamycin (P < 0.05; Fig. 7C,D) ; the opposite effect was seen for p62 ( Fig. 6C,E ). These findings suggest that activation of autophagy may play a role in neuroprotection in the presence of high glucose concentrations.
The molecular mechanism underlying the protective effects of autophagy in vitro was also connected with the inhibition of apoptosis. The number of TUNEL-positive cells was lower in high glucose + H 2 O 2 cells treated with rapamycin relative to controls (P < 0.05; Fig. 8B,C) . Similar levels of C-caspase 3 positive cells were detected by Immunohistochemistry, consistent with the TUNEL staining results (Fig. 8A,C) . Increases in the expression of both C-caspase 3 and Bax in response to high glucose were attenuated following addition of rapamycin (P < 0.05; Fig. 8D,E) ; down-regulation of Bcl2 was also alleviated by rapamycin application (P < 0.05; Fig. 8D,F) . Taken together, these data further confirm the neuroprotective role of autophagy activation in combination with inhibition of apoptosis in PC12 cells.
Discussion
Serious spinal cord injuries often result in lifelong disability and enormous economic costs. Vertebral impact injuries, such as those caused by traffic accidents, sports injuries, and other physical traumas, are not uncommon. In cases of substantial spinal cord injury, the initial trauma is followed by a long period of secondary damages, characterised by persistent oxidative stress, inflammation, necrosis and apoptosis 20, 21 . Similar molecular events are thought to play a key role in the pathophysiological degeneration of the injured spinal cord in diabetic rats, with diabetes-associated increases in apoptosis in the spinal cord significantly inhibiting recovery from spinal cord injury 4, 7 . The data presented here strongly support these observations, with upregulation of apoptosis seen in diabetic rats following spinal cord injury. Previous studies have shown that Bcl2 exerts an anti-apoptotic effect 22 , while Bax participates in the induction of apoptosis 23 ; activation of C-caspase 3 is seen as a hallmark of apoptotic cell death, acting as the final executor of apoptosis 24 . Western blot analyses revealed higher levels of both C-caspase 3 and Bax in the diabetes + SCI group relative to the SCI group, whereas expression of Bcl2 declined. Furthermore, Immunohistochemistry (for C-caspase 3) showed significant increases in the number of apoptosis-positive cells in the spinal cord lesions of diabetic rats. Double staining (for NeuN/TUNEL) also revealed that diabetes up-regulated the level of apoptosis in neurons from spinal cord lesions. Previous studies found that the inflammatory response 25 , astrocytic gliosis 26 and neurons loss 20 are three common indicators to reflect neurological damage of spinal cord injury. In our study, diabetic SCI revealed worse neurological damage, including increased inflammation, proliferation of astrocytes and neurons loss in lesion site. Based upon these data we conclude that STZ-induced diabetes significantly increased neurological damage and suppressed locomotor recovery after SCI in rats, due to increases in apoptosis.
Autophagy is a process of self-digestion whereby the cell degrades long-lived proteins and organelles as a means of generating the building blocks necessary to sustain cellular function 27 . While often considered solely as a response to starvation, autophagy has been shown to protect against pathologies, including neurodegenerative disorders 28 , infections 29 , inflammatory diseases 30 , and cancer 31 . Here, we show strong activation of both autophagy and apoptosis in the spinal cord lesions of diabetic rats, compared with non-diabetic controls. While the exact relationship between autophagy and apoptosis is not fully understood, previous studies have shown a direct relationship between autophagy activation and inhibition of apoptosis 13, 32 . The reverse scenario is also true, with the inhibition of autophagy associated with increases in apoptosis, which may contribute to neuronal damage in neurodegenerative disease 33 . However, this inverse regulation is not uniform across all cell types, with autophagy shown to play an important role in apoptosis in bystander CD4 T lymphocytes 34 . Similarly, Grishchuk et al. 35 found that Beclin 1-independent autophagy is an important contributor to both caspase-dependent and -independent components of neuronal apoptosis. In our model of diabetic SCI, we treated diabetic SCI rats with the autophagic agonist rapamycin to further determinate the relationship between autophagy and apoptosis. In the rapamycin treatment group, Bcl2 expression was increased in relation to the diabetes + SCI group, whereas the expressions of both C-caspase 3 and Bax declined, indicating that over-activation of autophagy inhibited the rate of apoptosis in diabetic SCI. In addition, rapamycin also reduced the degree of neuronal loss, and promoted functional recovery. Taken together, these results suggest that diabetes upregulated autophagy, increased apoptosis, and delayed locomotor recovery in spinal cord injury. Furthermore, stimulation of autophagy reduced neurological damage and promoted locomotor recovery via inhibition of apoptosis in diabetic SCI rats.
In the model described here, diabetes was induced via injection of a single large dose of STZ, a compound which specifically kills pancreatic β cells, mimicking the pathology of Type 1 diabetes 36, 37 . These STZ-treated rats exhibited significant hyperglycaemia, in addition to other important co-morbidities, including hyperphagia, polydipsia, and weight loss. The resulting diabetic rats exhibit worse functional recoveries than that of their healthy counterparts when subjected to the same level of SCI. Hyperglycaemia is a major contributing factor to the development of diabetes-related diseases. Several biochemical events have been associated with hyperglycaemia, including glucose-mediated increases in reactive oxygen species, as well as advanced glycation of important functional and structural proteins 38 , suggesting that hyperglycaemia is a key factor in the pathophysiological changes and lag in function recovery in our diabetic SCI model. To further examine hyperglycaemic-mediated autophagy and apoptosis in vitro, PC12 cells were treated with H 2 O 2 to cause oxidative damage, and then treated with high levels of glucose with or without rapamycin. The result showed that high glucose concentrations activated both apoptosis and autophagy in damaged PC12 cells, with glucose-induced apoptosis inhibited by the upregulation of autophagy.
As with all research, this work was not without limitations. One of the most significant limitations of this research is that the STZ-induced model of diabetes is reflective primarily of Type 1 diabetes, and therefore does not accurately recreate all aspects of the more common Type 2 diabetes. Second, since diabetic SCI rats have a higher mortality rate, the time course over which pathologies arise in the diabetic SCI model has not been established.
In conclusion, STZ-induced diabetes significantly exacerbated neurological damage and suppressed locomotor recovery after spinal cord injury in rats, in part through the enhanced activation of apoptosis. While increases in both autophagy and apoptosis were found to inhibit recovery from spinal cord injury in diabetic rats, further stimulation of autophagy improved the neurological function via inhibition of apoptosis. These data suggest a potential therapeutic strategy by which stimulation of autophagy may be beneficial for improving recovery from spinal cord injury in diabetic patients.
Materials and Methods
Animals. Adult female Sprague-Dawley rats (220-250 g) were purchased from Wenzhou Medical University (SCXK [Zhe] 2005-0019). Care and use of all animals conformed to the Guidelines set forth by the Chinese National Institutes of Health, with relevant study protocols approved by the Animal Care and Use Committee of Wenzhou Medical University (wydw2012-0079). Efforts were made to reduce the number of animals used in this study, and to minimise their suffering.
Cell culture and treatments. PC12 cells were purchased from the Cell Storage Centre of Wuhan University (Wuhan, China), and maintained at 37 °C in a humidified atmosphere containing 5% (v/v) CO 2 . Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Invitrogen, Grand Island, NY) supplemented with heat-inactivated 10% (v/v) foetal bovine serum (Gibco, Invitrogen, Grand Island, NY), and antibiotics (100 units/mL penicillin, 100 μ g/mL streptomycin). PC12 cells were maintained in DMEM supplemented with 4.5 mg/mL glucose, according to the manufacturer's instructions. High-glucose medium was defined as DMEM containing a threefold increased concentration of supplemental glucose (13.5 mg/mL). Cells were culture in DMEM for 24 h, transferred to fresh DMEM or high-glucose DMEM for 12 h, and then treated with H 2 O 2 (Sigma; 100 μ mol/L) for 2 h to induce oxidative injury. To further assess the effects of autophagy activation on high-glucose-induced injury, 
+ high glucose + rapamycin. Cells were then analysed using a cell counting kit-8 (CCK-8; Dojindo Co, Kumamoto, Japan), immunofluorescence, immunocytochemistry, and Western blot. All experiments were performed in triplicate.
Cell viability assay. Cell viability was assayed using the CCK-8 kit according to the manufacturer's instructions. In brief, PC12 cells were plated on 96-well plates at a density of 10 5 /mL, and incubated in DMEM at 37 °C for 24 h. Cells were then treated with H 2 O 2 , H 2 O 2 + high glucose, or H 2 O 2 + high glucose + rapamycin. Following incubation, cells were washed with PBS, 100 mL DMEM + 10 μ L CCK-8 solution were added to each well, followed by incubation for a further 2 h. The absorbance of the wells at 450 nm was then measured using a microplate reader.
Immunocytochemistry. PC12 cells were plated on slides in a six-well plate and treated with H 2 O 2 , H 2 O 2 + high glucose, or H 2 O 2 + high glucose + rapamycin, as described above. For immunocytochemistry staining, samples were fixed in 4% (w/v) paraformaldehyde for 15 min and permeabilised with 0.1% (v/v) PBS-Triton X-100 for 30 min. To block the activity of endogenous peroxidase, the slides were incubated in 3% H 2 O 2 for 15 min at room temperature. Cells were then blocked in 10% (v/v) bovine serum albumin in PBS for 1 h, and incubated with a primary antibody against cleaved caspase 3 (C-caspase 3; 1:400; Cell Signaling Technology, Danvers, MA) overnight at 4 °C. The next day, slides were washed and incubated with an horseradish peroxidase-conjugated secondary antibodies in PBS for 1 h, developed with DAB, and counterstained with haematoxylin. Finally, images were captured at × 400 magnification under a light microscope (Olympus, Tokyo, Japan). The C-caspase3 positive cells were automatically counted at eight randomly selected fields per sample by using the Image-Pro Plus (IPP) software, version 6.0 (Media Cybernetics, Rockville, MD).
Immunofluorescence. To Animal model of Type 1 diabetes. Sprague-Dawley rats were housed in a specific pathogen-free (SPF) room with a 12 h light/dark cycle and provided regular food and water for 1 week prior to any experimental procedure. One hundred and fifty rats were randomly divided into two groups: (1) control group, and (2) diabetes group. After fasting for 12 h, 70 rats in the diabetes group were intraperitoneally (i.p.) injected with 1% (w/v) streptozotocin (STZ) 60 mg/kg (Sigma-Aldrich, St. Louis, MO, USA) dissolved in citrate buffer (pH 4.0-4.4); the remaining 70 rats were fasted for 12 h and treated with a vehicle citrate buffer (1 mL/kg) as a control. All rats were given ad libitum access to the normal diet and tap water after injection. The fasting plasma glucose (FPG) of rats was measured in the tail blood with an autoanalyser (Roche, Mannheim, Germany). One week after STZ injection, FPG levels were tested, with levels > 16.7 mmol/L considered indicative of successful Type 1 diabetes induction. FPG levels and body weights were measured for all animals both before injection, as well as 7, 14, 21, and 28 days after injection. Six rats in the diabetes group died within 28 days after injection.
Animal model of SCI and drug administration. Within the control group, 70 rats were randomly divided into either the sham control or SCI group. Meanwhile, 64 diabetic rats were randomly divided into the diabetes + SCI or diabetes + SCI + rapamycin group. Rats in the SCI (n = 35), diabetes + SCI group (n = 32), and diabetes + SCI + rapamycin (n = 32) groups were subjected to induced SCI 4 weeks after STZ injection. Rats were anaesthetised by administration of 2% (w/v) pentobarbital sodium (40 mg/kg, Solarbio Science & Technology, Beijing, China) via intraperitoneal injection. There are 13 pairs of ribs in SD rats. As is well known, the T13 vertebrae is connected with the 13th ribs. And the 13th ribs and T13 vertebrae were determined in X-ray images (Fig. S1A ), which were taken by a animals digital X-ray machine (Kubtec Model XPERT.8; KUB Technologies Inc.). After that, the T9 vertebrae was located via the locating pin before the procedure of SCI (Fig. S1B) . Afterwards, the vertebral column was then exposed, and a laminectomy carried out carefully at the T9 vertebrae. The vertebrae were then subjected to a crushing injury via compression with a vascular clip (15 g force; Oscar, China) for 1 min to expose the spinal cord (Fig. 1C) . Rats in the sham control group (n = 35) were subjected to the same surgical procedure with the spinal cord was exposed for 1 min, but did not undergo the compression injury. After SCI, rats underwent manual urinary bladder emptying five times daily until bladder function returned. Cefazolin sodium (50 mg/kg/day, i.p.) was administrated to prevent bacterial infection. Rapamycin (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in DMSO (25 mg/mL) and further diluted in saline for intraperitoneal injection. Following spinal cord compression injury, rats in the diabetes + SCI + rapamycin group were treated with 1 mg/kg/day, while rats in the remaining groups were injected with the equivalent volume of vehicle for 7 days. All rats received daily rehabilitation, including passive mobilisation of the paralysed legs five times daily. Following completion of the trial, rats were euthanised using an overdose of pentobarbital sodium on day 7, with the exception of 20 rats, which were used to assess locomotion recovery.
Locomotion recovery assessment. The Basso, Beattie, and Bresnahan (BBB) locomotion rating scale 39 was used to assess locomotion recovery. BBB tests were conducted 3, 7, 14, 21 and 28 d after SCI; rats were laid on the floor and crawling ability was observed for 5 min. Outcome measures were obtained in a blinded fashion by independent examiners and averaged. In brief, BBB scores range from 0 points, which is indicative of complete paralysis, to 21 points which indicates normal locomotion. The inclined plane test 40 was also performed to assess locomotion recovery of all rats in each time point. In brief, all rats were tested in two positions (right side or left side up) on a testing apparatus (i.e., a board covered with a rubber mat containing horizontal ridges spaced 3 mm apart). For each position, the maximum angle at which a rat could maintain its position for 5 s without falling was recorded and averaged to obtain a single score for each rat.
Hematoxylin and Eosin (H&E) staining and Nissl staining. Rats (n = 5 per group) were re-anaesthetised with 2% (w/v) pentobarbital sodium (40 mg/kg, i.p.) and perfused with normal saline, followed by addition of 4% (w/v) paraformaldehyde in phosphate-buffered saline 7 days after surgery. Spinal cord segments (1 mm in length), that spanned a 3 mm length in the spinal cord centred at the epicentre were collected and fixed in 4% (w/v) paraformaldehyde for 24 h. Next, samples in each group were embedded in paraffin for transverse paraffin sections. The paraffin sections (4 μ m thick) mounted on poly-L-lysine-coated slides for histopathological examination by H&E staining. Meanwhile other sections were incubated in 1% (w/v) Cresyl violet for Nissl staining and observed under a light microscope (Olympus, Tokyo, Japan). The Nissl positive cells were automatically counted at eight randomly selected fields from grey matter area per sample by using the IPP software.
Immunohistochemistry. Rat spinal cord tissues (1 mm segments; n = 10 per group) were excised and fixed, as before. All samples were embedded in paraffin for either coronal or transverse paraffin sections, respectively. Paraffin sections (4 μ m thick) were mounted on poly-L-lysine-coated slides for immunohistochemistry; transverse paraffin sections (for NeuN, GFAP and CD68 ) and coronal paraffin sections (for C-caspase3 and LC3)were deparaffinised with xylene and rehydrated through graded ethanol. After washing, the sections were blocked with 3% (v/v) H 2 TdT-mediated dUTP biotin nick-end labelling (TUNEL). TUNEL was used to detect DNA fragmentation due to apoptotic signalling cascades in vivo and in vitro. Slides of PC12 cells were washed with distilled water, incubated with Proteinase K for 20 min at 37 °C, and analysed using the In Situ Cell Death Detection Kit (Roche Molecular Biochemicals) according to the manufacturer's instructions. Images were visualised using a fluorescence microscope (Olympus, Tokyo, Japan) at 200× magnification, and the TUNEL positive cells were automatically counted at eight randomly selected fields from slide per sample by using the IPP software.
Double staining of NeuN and TUNEL.
To identify DNA fragmentation in neurons, the transverse sections at 7d after SCI were double-stained for TUNEL and NeuN (a neurons marker). Sections were permeabilised with 0.1% (v/v) PBS-Triton X-100 for 30 min. After blocking in 10% (v/v) bovine serum albumin in PBS for 1 h, sections were incubated at 4 °C overnight with a primary antibody against NeuN (1:100, Abcam, Cambridge, MA, USA). After that, slides were washed 3 × 10 min at room temperature, and incubated with FITC-conjugated goat anti-rabbit IgG (1:200) antibody for 1 h at room temperature. Then, Sections were washed 3 × 10 min at room temperature again and analysed using the In Situ Cell Death Detection Kit (Roche Molecular Biochemicals) according to the manufacturer's instructions. Images were visualised using a fluorescence microscope (Olympus, Tokyo, Japan). The percentage of TUNEL positive neurons was automatically calculated at eight randomly selected fields from lesion site per sample by using the IPP software. Transmission electron microscopy (TEM). After fixation in 2.5% (w/v) glutaraldehyde overnight, spinal cord tissues were post-fixed in 2% (v/v) osmium tetroxide and blocked with 2% (v/v) uranyl acetate. Following dehydration in a series of acetone washes, tissues were embedded in Araldite for coronal sections. Semi-thin section and toluidine blue staining were performed for observation of location. Finally, ultra-thin sections of at least three blocks per sample were cut and observed using a Hitachi TEM.
Western blot analysis. Total proteins from spinal cord tissues and PC12 cells were purified using protein extraction reagents. Rat spinal cord segments (8 mm; containing the injury epicentre) (n = 5 per group) were dissected on day 7 following SCI. The equivalent of 60 μ g protein were separated on a 12% (w/v) gel and transferred onto a PVDF membrane (Bio-Rad Laboratories, Hercules, CA, USA). After blocking with 5% (w/v) non-fat milk for 2 h, the membranes were incubated with the following antibodies: Bax, C-caspase 3, Bcl2, Beclin1, p62 (1:1000; Cell Signaling Technology; Danvers, MA, USA), LC3 (1:500; Cell Signaling Technology; Danvers, MA, USA), and β -actin (1:200; Santa Cruz Biotechnology). Next, the membranes were incubated with a goat-anti-rabbit secondary antibody for 2 h at room temperature, and bands detected using the enhanced chemiluminescence (ECL) kit (PerkinElmer, Waltham, MA, USA). Band intensity was quantified using the Image Lab 3.0 software (Bio-Rad).
Statistical analysis. Statistical analyses were carried out using the SPSS.20 statistical software. All values are presented as the means ± standard error of the mean (SEM). Statistical evaluation of the data was performed by one-way ANOVA followed by a post hoc comparison test using the LSD (equal variances assumed) or Dunnett's T3 (equal variances not assumed) method. P values < 0.05 were considered to indicate statistical significance.
